Federated Hermes’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-177
Closed -$2.66K 2164
2024
Q3
$2.66K Sell
177
-86,231
-100% -$1.3M ﹤0.01% 1923
2024
Q2
$2.47M Sell
86,408
-9,045
-9% -$259K 0.01% 881
2024
Q1
$2.79M Sell
95,453
-281,204
-75% -$8.22M 0.01% 851
2023
Q4
$12.7M Sell
376,657
-11,810
-3% -$398K 0.03% 509
2023
Q3
$11.9M Sell
388,467
-19,591
-5% -$601K 0.03% 493
2023
Q2
$16.4M Buy
408,058
+258,394
+173% +$10.4M 0.04% 436
2023
Q1
$6.11M Buy
149,664
+149,619
+332,487% +$6.11M 0.02% 653
2022
Q4
$1.74K Sell
45
-149
-77% -$5.75K ﹤0.01% 2016
2022
Q3
$10K Sell
194
-205
-51% -$10.6K ﹤0.01% 1837
2022
Q2
$23K Sell
399
-80,543
-100% -$4.64M ﹤0.01% 1753
2022
Q1
$6.18M Sell
80,942
-302
-0.4% -$23K 0.01% 728
2021
Q4
$4.89M Buy
81,244
+19,112
+31% +$1.15M 0.01% 815
2021
Q3
$3.48M Sell
62,132
-55,888
-47% -$3.13M 0.01% 908
2021
Q2
$7.16M Sell
118,020
-19,998
-14% -$1.21M 0.01% 746
2021
Q1
$9.67M Sell
138,018
-44,662
-24% -$3.13M 0.02% 666
2020
Q4
$10.9M Buy
182,680
+4,275
+2% +$256K 0.02% 615
2020
Q3
$10.7M Buy
178,405
+74,396
+72% +$4.47M 0.03% 555
2020
Q2
$5.46M Buy
104,009
+85,673
+467% +$4.49M 0.01% 690
2020
Q1
$615K Buy
18,336
+16,035
+697% +$538K ﹤0.01% 1314
2019
Q4
$104K Sell
2,301
-115,249
-98% -$5.21M ﹤0.01% 1674
2019
Q3
$4.48M Sell
117,550
-112,460
-49% -$4.28M 0.01% 796
2019
Q2
$10M Buy
230,010
+22,173
+11% +$964K 0.02% 583
2019
Q1
$7.91M Sell
207,837
-56,132
-21% -$2.14M 0.02% 646
2018
Q4
$11.4M Buy
263,969
+79,415
+43% +$3.42M 0.03% 449
2018
Q3
$9.07M Buy
+184,554
New +$9.07M 0.02% 603
2015
Q1
Sell
-15,094
Closed -$1.34M 2056
2014
Q4
$1.34M Hold
15,094
﹤0.01% 1089
2014
Q3
$1.46M Buy
15,094
+3,290
+28% +$319K ﹤0.01% 1075
2014
Q2
$1.08M Buy
+11,804
New +$1.08M ﹤0.01% 1170